Treatment Arm for Overactive Bladder

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Overactive Bladder+1 MoreCiprofloxacin - Drug
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial will compare the rate of bladder infection after Botox injection in women who received antibiotics versus those who received a placebo.

Eligible Conditions
  • Post-operative Urinary Tract Infection
  • Overactive Bladder

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Similar Trials

1
probiotics plus antibiotic
1
Maintenance group
2
PEEZy collection BMI < 30

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 1, 2 and 6 weeks following the procedure

Week 6
Rate of Postoperative Urinary Tract Infection Rate
Week 6
Rate of Other Adverse Events
Week 2
Rate of Postoperative Urinary Tract Infection

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
probiotics plus antibiotic
1
Maintenance group
3
PEEZy collection BMI < 30

Trial Design

2 Treatment Groups

Treatment Arm
1 of 2
Placebo Arm
1 of 2

Active Control

Non-Treatment Group

202 Total Participants · 2 Treatment Groups

Primary Treatment: Treatment Arm · Has Placebo Group · Phase 4

Treatment Arm
Drug
ActiveComparator Group · 1 Intervention: Ciprofloxacin · Intervention Types: Drug
Placebo Arm
Other
PlaceboComparator Group · 1 Intervention: Placebo Pill · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1, 2 and 6 weeks following the procedure

Who is running the clinical trial?

University of AlbertaLead Sponsor
815 Previous Clinical Trials
376,592 Total Patients Enrolled
Women and Children's Health Research Institute, CanadaOTHER
16 Previous Clinical Trials
24,558 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
and are not surgical candidates will be considered for sacral neuromodulation Patients who have idiopathic overactive bladder (OAB) and have failed medical management will be considered for sacral neuromodulation if they are not surgical candidates.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top